Friday, March 3, 2023

EHC Program Update: Draft Reports on PTSD and Cancer Care Available for Comment; Genitourinary Symptoms of Menopause Protocol Available

AHRQ Effective Health Care

Opportunity to Comment on Draft Reports

We encourage the public to participate in the development of our research projects. Comments can be submitted for: 

Measuring Healthcare Organization Characteristics in Cancer Care Delivery Research
(Available for comment until April 2, 2023)

The purpose of this Technical Brief was to identify: 1) frameworks that have been developed or applied to examine the effects of organizational characteristics on the delivery of and outcomes associated with cancer screening, diagnosis, and treatment, and compare these frameworks to the Integrated Framework recently developed by Weaver, Breslau, and colleagues; 2) approaches used to improve understanding of how organizational context and process characteristics are described, measured, and analyzed in the context of cancer screening, diagnosis, and treatment; 3) healthcare organizational context and process characteristics that have been examined in studies assessing the delivery of cancer screening, diagnosis, and treatment; and 4) evidence gaps and future research needs.

Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: An Update of the Evidence Base for the PTSD Trials Standardized Data Repository
(Available for comment until March 28, 2023)

The purpose of the review is to identify and abstract data from randomized controlled trials examining treatment for posttraumatic stress disorder (PTSD) and comorbid PTSD/substance use disorder to update the previous AHRQ report on this topic and the National Center for PTSD (NCPTSD) PTSD Trials Standardized Data Repository with newly published trials.


Opportunity to Submit Scientific Information

The Effective Health Care (EHC) Program is interested in receiving supplemental evidence and data (SEADs) for systematic reviews that are relevant to the questions in our evidence reports. To ensure that it has full access to relevant research, whether or not it is published, the EHC Program is interested in receiving SEADs containing detailed study-specific information. Opportunities to submit scientific information are available for:

Genitourinary Symptoms of Menopause
(Available for submission until March 29, 2023)

Given the range of symptoms associated with genitourinary syndrome of menopause, the lack of definitive diagnostic criteria, the impact of these symptoms, and the increasing number and range of available treatments, this review will assist clinicians, patients, and other stakeholders to make informed decisions about screening, evaluation, and treatment. 

(Section 944 (c) of the Public Health Service Act [42 U.S.C. 299c 3(c)] requires that information collected for research conducted or supported by AHRQ that identifies individuals or establishments be used only for the purpose for which it was supplied unless they consent to the use of the information for another purpose.)

 

About us: AHRQ's Effective Health Care Program is committed to providing the best available evidence on the outcomes, benefits and harms, and appropriateness of drugs, devices, and health care services and by helping health care professionals, patients, policymakers, and health care systems make informed health care decisions. The program partners with research centers, academic institutions, health professional societies, consumer organizations, and other stakeholders to conduct research, evidence synthesis, evidence translation, dissemination, and implementation of research findings.

To learn more: https://effectivehealthcare.ahrq.gov/

Contact us at epc@ahrq.hhs.gov


This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: Agency for Healthcare Research and Quality (AHRQ) · 5600 Fishers Lane, Rockville, MD 20857 · 301-427-1364 

No comments:

Post a Comment

BoF VOICES 2024: Alessandro Michele, Nicky Doll and More

Tapestry-Capri Deal Called Off; Burberry's Course Correction; Alexandre Arnault's New Role ADVERTISEMENT WHAT...